Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis
1 other identifier
observational
30
1 country
1
Brief Summary
The purpose of this study is to determine whether the monoclonal protein in patients with tuberculosis and monoclonal gammopathy has anti-tuberculous activity, and whether genes coding their monoclonal proteins show characteristic mutations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2005
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 12, 2005
CompletedFirst Posted
Study publicly available on registry
September 15, 2005
CompletedSeptember 15, 2005
May 1, 2005
September 12, 2005
September 12, 2005
Conditions
Eligibility Criteria
You may qualify if:
- Monoclonal Gammopathy with Tuberculosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Laboratory Medicine, National Taiwan Univeristy Hospital
Taipei, 100, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
LINA LEE, MD,PhD
Department of labrotoary medicine,National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 12, 2005
First Posted
September 15, 2005
Study Start
June 1, 2005
Study Completion
June 1, 2005
Last Updated
September 15, 2005
Record last verified: 2005-05